Institutional investors purchased a net $3.9 million shares of THRX during the quarter ended March 2013. This may signal that the smart money is gaining interest in this company as the 76.63% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BANK OF AMERICA NA (PRIVATE BANK... Bought 1.6 Million shares of Theravance Inc